(Q34631438)

3 August 2017

1 reference

title

Mechanisms of bacterial biocide and antibiotic resistance. (English)

1 reference

3 August 2017

antibiotic resistance

1 reference

Poole K

1

1 reference

3 August 2017

1 January 2002

1 reference

Journal of Applied Microbiology

3 August 2017

1 reference

3 August 2017

92 Suppl

1 reference

3 August 2017

55S-64S

1 reference

An Enzyme from Bacteria able to Destroy Penicillin

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Prevention of marine biofouling using natural compounds from marine organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Reaction of acylated homoserine lactone bacterial signaling molecules with oxidized halogen antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

The multidrug efflux protein NorM is a prototype of a new family of transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Activity of cefepime and other beta-lactam antibiotics against permeability mutants of Escherichia coli and Klebsiella pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Transferable resistance to triclosan in MRSA

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Role of biofilms in antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Molecular basis for resistance to silver cations in Salmonella

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

beta-lactam resistance in Streptococcus pneumoniae: penicillin-binding proteins and non-penicillin-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

The bacterial outer membrane as a drug barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Pseudomonas aeruginosa biofilm sensitivity to biocides: use of hydrogen peroxide as model antimicrobial agent for examining resistance mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Mechanism of triclosan inhibition of bacterial fatty acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Mechanisms of action and resistance of older and newer fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

The drug/metabolite transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Inducible NorA-mediated multidrug resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Antibiotic and antiseptic resistance: impact on public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Molecular basis of triclosan activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Epidemiology of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Molecular cloning and characterization of acrA and acrE genes of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Mechanisms of biofilm resistance to antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Expression of the multiple antibiotic resistance operon (mar) during growth of Escherichia coli as a biofilm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Evidence that halogenated furanones from Delisea pulchra inhibit acylated homoserine lactone (AHL)-mediated gene expression by displacing the AHL signal from its receptor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Contributions of the AmpC beta-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to beta-lactams

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Triclosan targets lipid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Bacterial detoxification of Hg(II) and organomercurials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Evidence for chloramphenicol/H+ antiport in Cmr (MdfA) system of Escherichia coli and properties of the antiporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Prevention of drug access to bacterial targets: permeability barriers and active efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Antibiotic resistance caused by gram-negative multidrug efflux pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Multiple antibiotic resistance and efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

The 3' conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Overcoming antimicrobial resistance by targeting resistance mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Molecular properties of bacterial multidrug transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

AcrD of Escherichia coli is an aminoglycoside efflux pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Crystallographic analysis of triclosan bound to enoyl reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Plasmids and bacterial resistance to biocides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Contribution of the MexAB-OprM multidrug efflux system to the beta-lactam resistance of penicillin-binding protein and beta-lactamase-derepressed mutants of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Structural basis and mechanism of enoyl reductase inhibition by triclosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Triclosan and antibiotic resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Cytological changes in chlorhexidine-resistant isolates of Pseudomonas stutzeri.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a "residual" concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Antibiotic-supersusceptible mutants of Escherichia coli and Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

The ABC family of multidrug transporters in microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Membranotropic effects of the antibacterial agent Triclosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Handwashing in a neonatal intensive care nursery: product acceptability and effectiveness of chlorhexidine gluconate 4% and triclosan 1%

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Erythromycin resistance by ribosome modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Outer membrane protein shifts in biocide-resistant Pseudomonas aeruginosa PAO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Aminoglycoside-modifying enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Resisting resistance: new chemical strategies for battling superbugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

Multidrug resistance mechanisms: drug efflux across two membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2672.92.5S1.8.X

10.1046/J.1365-2672.92.5S1.8.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12000613